My biotech business journal watch - year 2000 [ this week | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 ]

 Can't find the biotech business article published in 2000 in my site? 
Try a Google search!
Google

  1. Cyranoski D. Japanese genomics company offers shares in sequences. Nature. 2000 Dec 21-28;408(6815):889. [PubMed][pdf]
  2. Gold ER. Moving the gene patent debate forward. Nat Biotechnol. 2000 Dec;18(12):1319-1320. [PubMed]
  3. Niiler E. Company, academics argue over data. Nat Biotechnol. 2000 Dec;18(12):1235. [PubMed]
  4. Saviotti PP, deLooze MA, Michelland S, Catherine D. The changing marketplace of bioinformatics. Nat Biotechnol. 2000 Dec;18(12):1247-1249. [PubMed]
  5. Affymetrix spins off firm. Nat Biotechnol. 2000 Nov;18(11):1128. [PubMed]
  6. Eisenberg RS. Genomics in the public domain: strategy and policy. Nat Rev Genet. 2000 Oct 1:70-74
  7. Harris T. Clear vision for a structure-seeking business. Nat Biotechnol. 2000 Oct;18(10):1017. [PubMed]
  8. Biotech exec jailed. Nat Biotechnol. 2000 Oct;18(10):1024. [PubMed]
  9. IBM invests in life sciences. Nat Biotechnol. 2000 Oct;18(10):1024 [PubMed]
  10. Internet chat damages biotechnology stocks. Nat Biotechnol. 2000 Oct;18(10):1030-1031. [PubMed]
  11. Fletcher L. Efforts to commercialize structural genomics may be limited. Nat Biotechnol. 2000 Oct;18(10):1036. [PubMed]
  12. Crespi R. Stephen. Genomics, proteomics, and patents. Trends Biotechnol. 2000 Oct 18:405-406.
  13. Grisham J. New rules for gene patents. Nature Biotech. 2000 Sep 1; 18 (9):921.[PubMed]
  14. Emma Dorey. G-8 leaders fudge biotech position. Nature Biotech. 2000 Sep 1; 18 (9):923 - 924.[PubMed]
  15. Darryl Macer & Mary Ann Chen Ng. Changing attitudes to biotechnology in Japan  Nature Biotech. 2000 Sep 1; 18 (9): 945 - 947[PubMed]
  16. Reichert JM.  New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999. Trends Biotechnol. 2000 Sep;18(9):364-369. [PubMed]
  17. Walsh G. Biopharmaceutical benchmarks. Nat Biotechnol. 2000 Aug;18(8):831-3. [PubMed]
  18. Barton JH. Rational limits on genomic patents. Nat Biotechnol. 2000 Aug;18(8):805. [PubMed]
  19. Smaglik P.  Shares rebound at scent of draft sequence. Nature. 2000 Jun 22;405(6789):875. [PubMed][pdf]
  20. Dickson D. NIH opposes plans for patenting 'similar' gene sequences. Nature. 2000 May 4;405(6782):3. [PubMed][pdf]
  21. Smaglik P. Shareholder sues Celera over loss. Nature. 2000 May 4;405(6782):3. [PubMed]
  22. Triendl R. Japan gears up for growth in genomics. Nature. 2000 Apr 27;404(6781):913. [PubMed][pdf]
  23. Dickson D. Affymetrix loses first round of patent battle. Nature. 2000 Apr 13;404(6779):697. [PubMed]
  24. Butler D. IBM joins genomics mapping consortium. Nature. 2000 Feb 3;403(6769):473. [PubMed]
  25. Private vs public genomics? Nature. 2000 Jan 13;403(6766):117. [PubMed]
  26. Dickson D. Internet fervour hits genomics. Nature. 2000 Jan 13;403(6766):119-20. [PubMed]
  27. Butler D, Smaglik P. Celera genome licensing terms spark concerns over 'monopoly'. Nature. 2000 Jan 20;403(6767):231. [PubMed]

last updated: 27 Jan 2001
home